Report Detail

The North America PACS and RIS market is expected to reach US$ 2,059.67 Mn in 2027 from US$ 1,107.50 Mn in 2018. The market is estimated to grow with a CAGR of 7.6% from 2019-2027.
The growth of the PACS and RIS market is primarily attributed to the affordable price of new generation PACS software and rising prevalence of dental diseases. However, concerns regarding data privacy is likely to pose a negative impact on the market growth. On the other hand, increasing demand for orthopaedic PACS is likely to have a positive impact on the growth of the North America PACS and RIS market in the coming years.
Tooth loss is one of the sensitive indicator of access to dental care and overall dental health. In a broad perspective, the prevalence of both partial and total tooth loss in adults and seniors has decreased since the early 1970s, according to a study by National Health Services. In spite of these improvement, significant disparities remain in some population groups related to tooth loss and insufficient dental care. As per the World health Organization’s, Global Burden of Disease Study 2016 estimated that around 3.58 billion people across the globe suffer from dental caries (tooth decay) in permanent teeth. The WHO also states that periodontal (gum) disease, which is a prominent cause of tooth loss was estimated to be the 11th most prevalent disease on a global scale. According to the American College of Prosthodontists (ACP), 178 million Americans are missing at least one tooth. Additionally, an average of 40 million people in the US are missing all of their teeth. The ACP estimates that this number is expected to rise over the next two decades owing to increasing cavity and tooth decay. According to a Brazilian study published in the International Journal of Dentistry, the major reasons responsible for dental implant procedures in Brazil were, Cavities (38.4%), periodontal diseases (32.2%), eruption problems (6.4%), orthodontics (5.7%), prosthetics (3.6%), injury/trauma (2.6%), occlusal problems (1.1%), and others (9%). Furthermore, American Dental Association (ADA) statistics 2015, ninety-one percent of Americans over the age of 20 years have suffered from dental cavities at least once in their lives. The high prevalence of dental issues will boost the adoption of PACS and RIS in the coming few years.
In 2018, the Picture Archive and Communication System (PACS) segment held the most significant market share of the PACS and RIS market, by product. This segment is also anticipated to dominate the market in 2027 as the solution offers benefits such as improved viewing and analysis, easy access to images and other reports, efficient data management as well as a user-friendly interface. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the software segment held a most significant market share of the PACS and RIS market, by component. This segment is also estimated to dominate the market in 2027 since software form an integral part of PACS and RIS. Software used in PACS and RIS is a central-server solution that offers all clinics and departments assistance during procedures. Also, the segment is also anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
In 2018, the web-based segment held the most significant market share of the PACS and RIS market, by deployment. This segment is also projected to dominate the market in 2027 due to benefits such as enhanced service for physicians as well as improved patient care. However, the cloud-based segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027, due to the increased adoption as well as the development of cloud-based solutions.
In 2018, the hospitals segment held a considerable market share of the PACS and RIS market, by end user. This segment is also predicted to dominate the market in 2027 owing to the availability of better healthcare facilities as well as the presence of reimbursement policies that lead to growth in the number of procedures conducted. Also, the segment is anticipated to witness growth at a significant rate during the forecast period, 2018 to 2027.
Some of the major primary and secondary sources for PACS and RIS included in the report are, The American Dental Association (ADA), The American Heart Association (AHA), Business Monitor International (BMI), The Canadian Association of Radiologists (CAR), The Food and Drug Administration (FDA) and others.


TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance

    2. North America PACS and RIS Market - Key Takeaways

      3. North America PACS and RIS Market - Market Landscape

      • 3.1 Overview
      • 3.2 Market Segmentation
        • 3.2.1 North America PACS and RIS Market - By Product
        • 3.2.2 North America PACS and RIS Market - By Component
        • 3.2.3 North America PACS and RIS Market - By Deployment
        • 3.2.4 North America PACS and RIS Market - By End User
        • 3.2.5 North America PACS and RIS Market - By Country
      • 3.3 PEST Analysis

      4. North America PACS and RIS Market - Key Market Dynamics

      • 4.1 Key Market Drivers
        • 4.1.1 Affordable Price of New Generation PACS Software
        • 4.1.2 Rising Prevalence of Dental Diseases
      • 4.2 Key Market Restraints
        • 4.2.1 Concerns Regarding Data Privacy
      • 4.3 Key Market Opportunities
        • 4.3.1 Increasing Demand for Orthopaedic PACS
      • 4.4 Trend
        • 4.4.1 Continuous Technological Advancements
      • 4.5 Impact Analysis

      5. PACS and RIS Market - North America Analysis

      • 5.1 North America PACS and RIS Market Revenue Forecasts And Analysis
      • 5.2 Market Positioning
      • 5.3 Company Share By Geography (2018)

      6. North America PACS and RIS Market Analysis - By Product

      • 6.1 Overview
      • 6.2 North America PACS and RIS Market By Product, 2018 & 2027 (%)
      • 6.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 6.4 Picture Archive and Communication System (PACS) Market
        • 6.4.1 Overview
        • 6.4.2 North America Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)
      • 6.5 Radiology Information System (RIS) Market
        • 6.5.1 Overview
        • 6.5.2 North America Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)

      7. North America PACS and RIS Market Analysis - By Component

      • 7.1 Overview
      • 7.2 North America PACS and RIS Market, By Component, 2018 & 2027 (%)
      • 7.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
      • 7.4 Software Market
        • 7.4.1 Overview
        • 7.4.2 North America Software Market Revenue and Forecasts to 2027 (US$ Mn)
      • 7.5 Hardware Market
        • 7.5.1 Overview
        • 7.5.2 North America Hardware Market Revenue and Forecasts to 2027 (US$ Mn)
      • 7.6 Services Market
        • 7.6.1 Overview
        • 7.6.2 North America Services Market Revenue and Forecasts to 2027 (US$ Mn)

      8. Global PACS and RIS Market Analysis- by Deployment

      • 8.1 Overview
      • 8.2 North America PACS and RIS Market, By Deployment 2018 & 2027 (%)
      • 8.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
      • 8.4 Web-Based Market
        • 8.4.1 Overview
        • 8.4.2 North America Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5 On-Premise Market
        • 8.5.1 Overview
        • 8.5.2 North America On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.6 Cloud-Based Market
        • 8.6.1 Overview
        • 8.6.2 North America Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)

      9. North America PACS and RIS Market Analysis- by End User

      • 9.1 Overview
      • 9.2 North America PACS and RIS Market, By End User 2018 & 2027 (%)
      • 9.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 9.4 Hospitals Market
        • 9.4.1 Overview
        • 9.4.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5 Diagnostic Centers Market
        • 9.5.1 Overview
        • 9.5.2 North America Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.6 Others Market
        • 9.6.1 Overview
        • 9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

      10. North America PACS and RIS Market Revenue and Forecasts To 2027

      • 10.1 Overview
      • 10.2 North America PACS and RIS Market Revenue And Forecasts to 2027 (US$ Mn)
      • 10.3 North America PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 10.4 North America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
      • 10.5 North America PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
      • 10.6 North America PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 10.7 North America PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
        • 10.7.1 US PACS and RIS Market Revenue and Forecasts To 2027 (US$ Mn)
          • 10.7.1.1 US PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.7.1.2 US PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 10.7.1.3 US America PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
          • 10.7.1.4 US PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
          • 10.7.1.5 US PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
        • 10.7.2 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.7.2.1 Canada PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.7.2.2 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 10.7.2.3 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
          • 10.7.2.4 Canada PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
          • 10.7.2.5 Canada PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
        • 10.7.3 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.7.3.1 Mexico PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.7.3.2 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 10.7.3.3 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
          • 10.7.3.4 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
          • 10.7.3.5 Mexico PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)

        11. PACS and RIS Market - Industry Landscape

        • 11.1 Overview
        • 11.2 Growth Strategies In The PACS and RIS Market, 2016-2019
        • 11.3 Inorganic Growth Strategies
          • 11.3.1 Overview
        • 11.4 Inorganic Growth Strategies in the PACS and RIS Market, 2016-2019 (%)
          • 11.4.1 Collaborations
            • 11.4.1.1 Recent Collaborations By Players In The PACS and RIS Market
          • 11.4.2 Agreements, Partnerships and Joint Ventures
            • 11.4.2.1 Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market
          • 11.4.3 Acquisitions
            • 11.4.3.1 Recent Acquisitions By Players In The PACS and RIS Market
        • 11.5 Organic Growth Strategies
          • 11.5.1 Overview
        • 11.6 Organic Growth Strategies in the PACS and RIS Market, 2016-2019 (%)
          • 11.6.1 Product Launches
            • 11.6.1.1 Recent Product Launches By Players In The PACS and RIS Market
          • 11.6.2 Product Approval & Other Organic Growth Strategies
            • 11.6.2.1 Recent Product Approval & Other Organic Growth Strategies By Players In The PACS and RIS Market

          12. PACS and RIS Market-Key Company Profiles

          • 12.1 Agfa-Gevaert Group
            • 12.1.1 Key Facts
            • 12.1.2 Business Description
            • 12.1.3 Financial Overview
            • 12.1.4 Product Portfolio
            • 12.1.5 SWOT Analysis
            • 12.1.6 Key Developments
          • 12.2 INFINITT Healthcare Co., Ltd.
            • 12.2.1 Key Facts
            • 12.2.2 Business Description
            • 12.2.3 Financial Overview
            • 12.2.4 Product Portfolio
            • 12.2.5 SWOT Analysis
            • 12.2.6 Key Developments
          • 12.3 McKesson Corporation
            • 12.3.1 Key Facts
            • 12.3.2 Business Description
            • 12.3.3 Financial Overview
            • 12.3.4 Product Portfolio
            • 12.3.5 SWOT Analysis
            • 12.3.6 Key Developments
          • 12.4 Cerner Corporation
            • 12.4.1 Key Facts
            • 12.4.2 Business Description
            • 12.4.3 Financial Overview
            • 12.4.4 Product Portfolio
            • 12.4.5 SWOT Analysis
            • 12.4.6 Key Developments
          • 12.5 General Electric Company
            • 12.5.1 Key Facts
            • 12.5.2 Business Description
            • 12.5.3 Financial Overview
            • 12.5.4 Product Portfolio
            • 12.5.5 SWOT Analysis
            • 12.5.6 Key Developments
          • 12.6 Koninklijke Philips N.V.
            • 12.6.1 Key Facts
            • 12.6.2 Business Description
            • 12.6.3 Financial Overview
            • 12.6.4 Product Portfolio
            • 12.6.5 SWOT Analysis
            • 12.6.6 Key Developments
          • 12.7 FUJIFILM Holdings Corporation
            • 12.7.1 Key Facts
            • 12.7.2 Business Description
            • 12.7.3 Financial Overview
            • 12.7.4 Product Portfolio
            • 12.7.5 SWOT Analysis
            • 12.7.6 Key Developments
          • 12.8 Siemens AG
            • 12.8.1 Key Facts
            • 12.8.2 Business Description
            • 12.8.3 Financial Overview
            • 12.8.4 Product Portfolio
            • 12.8.5 SWOT Analysis
            • 12.8.6 Key Developments
          • 12.9 IBM
            • 12.9.1 Key Facts
            • 12.9.2 Business Description
            • 12.9.3 Financial Overview
            • 12.9.4 Product Portfolio
            • 12.9.5 SWOT Analysis
            • 12.9.6 Key Developments
          • 12.10 Novarad
            • 12.10.1 Key Facts
            • 12.10.2 Business Description
            • 12.10.3 Financial Overview
            • 12.10.4 Product Portfolio
            • 12.10.5 SWOT Analysis
            • 12.10.6 Key Developments

          13. Appendix

          • 13.1 About The Insight Partners
          • 13.2 Glossary Of Terms
          • 13.3 Methodology
            • 13.3.1 Coverage
            • 13.3.2 Secondary Research

      Summary:
      Get latest Market Research Reports on North America PACS and RIS . Industry analysis & Market Report on North America PACS and RIS is a syndicated market report, published as North America PACS and RIS Market to 2027 - Regional Analysis and Forecasts by Product (PACS and RIS), Component (Hardware, Software, and Services), Deployment (Web-Based, On-Premise and Cloud-Based), End User (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Other End Users), and Country. It is complete Research Study and Industry Analysis of North America PACS and RIS market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,000.00
      $4,000.00
      $5,000.00
      2,409.00
      3,212.00
      4,015.00
      2,817.00
      3,756.00
      4,695.00
      463,620.00
      618,160.00
      772,700.00
      250,740.00
      334,320.00
      417,900.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report